Compare VTRS & AR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VTRS | AR |
|---|---|---|
| Founded | 1961 | 2002 |
| Country | United States | United States |
| Employees | 30000 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 10.7B |
| IPO Year | 2019 | 2013 |
| Metric | VTRS | AR |
|---|---|---|
| Price | $15.72 | $37.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 15 |
| Target Price | $11.83 | ★ $44.53 |
| AVG Volume (30 Days) | ★ 10.0M | 5.0M |
| Earning Date | 05-27-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | ★ 1027.78 |
| EPS | N/A | ★ 2.03 |
| Revenue | ★ $14,299,900,000.00 | $5,275,823,000.00 |
| Revenue This Year | N/A | $21.92 |
| Revenue Next Year | $1.60 | $5.73 |
| P/E Ratio | ★ N/A | $18.14 |
| Revenue Growth | N/A | ★ 21.97 |
| 52 Week Low | $6.85 | $29.10 |
| 52 Week High | $16.47 | $44.02 |
| Indicator | VTRS | AR |
|---|---|---|
| Relative Strength Index (RSI) | 61.83 | 62.88 |
| Support Level | $9.63 | $36.81 |
| Resistance Level | $16.30 | $38.18 |
| Average True Range (ATR) | 0.51 | 1.50 |
| MACD | -0.14 | 0.25 |
| Stochastic Oscillator | 56.25 | 75.51 |
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Antero Resources, based in Denver, explores for and produces natural gas and natural gas liquids in the United States and Canada. At the end of 2025, the company reported proven reserves of 19.1 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,442 million cubic feet of equivalent per day in 2025 at a ratio of 35% liquids and 65% natural gas.